The metallothionein and RCAS1 expression analysis in breast cancer and adjacent tissue regarding the immune cells presence and their activity

被引:0
作者
Popiela, Tadeusz J.
Rudnicka-Sosin, Lucyna
Dutsch-Wicherek, Magdalena
Klimek, Marek
Basta, Pawel
Galazka, Krystyna
Wicherek, Lukasz
机构
[1] Jagiellonian Univ, Gynecol Obstet & Oncol Dept, PL-31501 Krakow, Poland
[2] Jagiellonian Univ, Dept Gen Surg 1, Krakow, Poland
[3] Jagiellonian Univ, Dept Pathomorphol, Krakow, Poland
[4] Jagiellonian Univ, ENT Dept, Krakow, Poland
[5] Jagiellonian Univ, Dept Gynecol & Infertil, Krakow, Poland
关键词
metallothionein; RCAS1; expression; breast cancer; cytotoxic immune cells; tumor; TUMOR-INFILTRATING LYMPHOCYTES; HUMAN CERVICAL-CARCINOMA; DOWN-REGULATION; ANTIGEN RCAS1; POSTTRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; T-LYMPHOCYTES; APOPTOSIS; INDUCTION; PROLIFERATION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
INTRODUCTION: The generation of proper immune response in the tumor environment seems to be essential in antitumor defense. RCAS1 expression has been shown to participate in the regulation of immune cytotoxic activity, metallothionein participates in the protection of cells against immune mediated apoptosis. Since MT and RCAS1 expression is observed within healthy tumor environment we aimed to focus on the proteins expression in tumor and its healthy adjacent tissue in invasive ductal breast cancer regarding the immune cells presence and activity. MATERIAL AND METHODS: RCAS1, metallothionein, CD3, CD56, CD4, CD25, CD69, CD68 and CD16 antigens expression was assessed by immunohistochemistry in invasive ductal breast cancer. Tissue samples were obtained from 45 patients and were grouped according to the presence of lymph nodes metastases. Two groups were obtained: with and without lymph nodes metastases. RESULTS: Significant differences were observed in RCAS1 and metallothionein expression in tumor and significant differences in metallothionein expression in healthy stroma regarding the presence of lymph nodes metastases. The significantly higher RCAS1 expression was noticed in tumor in comparison to stroma in patients with the presence of lymph nodes metastases. No such difference was observed in patients without the metastases. Significantly higher metallothionein expression was identified in tumor than in stroma in both groups of patients, with and without lymph nodes metastases. These changes in RCAS1 and metallothionein expression were significantly related with the changes in the number and activity of immune cells. CONCLUSION: RCAS1 and metallothionein expression in breast cancer healthy stroma seems to be essential for the coexistence of cytotoxic immune cells and normal epithelial cells. The loss of the ability to compensate the growing cytotoxic immune response in the environment might participate in the development of tumor spread.
引用
收藏
页码:786 / 794
页数:9
相关论文
共 54 条
  • [1] AbdelMageed AB, 1997, CANCER GENE THER, V4, P199
  • [2] Metallothionein isoform expression by breast cancer cells
    Barnes, NL
    Ackland, ML
    Cornish, EJ
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2000, 32 (08) : 895 - 903
  • [3] IMMUNOHISTOCHEMICAL DEMONSTRATION OF METALLOTHIONEIN IN NORMAL HUMAN BREAST-TISSUE AND BENIGN AND MALIGNANT BREAST-LESIONS
    BIER, B
    DOUGLASJONES, A
    TOTSCH, M
    DOCKHORNDWORNICZAK, B
    BOCKER, W
    JASANI, B
    SCHMID, KW
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1994, 30 (03) : 213 - 221
  • [4] HISTOLOGICAL GRADING AND PROGNOSIS IN BREAST CANCER - A STUDY OF 1409 CASES OF WHICH 359 HAVE BEEN FOLLOWED FOR 15 YEARS
    BLOOM, HJG
    RICHARDSON, WW
    [J]. BRITISH JOURNAL OF CANCER, 1957, 11 (03) : 359 - &
  • [5] Interactions of metallothionein with murine lymphocytes: Plasma membrane binding and proliferation
    Borghesi, LA
    Youn, J
    Olson, EA
    Lynes, MA
    [J]. TOXICOLOGY, 1996, 108 (1-2) : 129 - 140
  • [6] Cai L, 1998, ANTICANCER RES, V18, P4667
  • [7] Metallothioneins in human tumors and potential roles in carcinogenesis
    Cherian, M. George
    Jayasurya, A.
    Bay, Boon-Huat
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2003, 533 (1-2) : 201 - 209
  • [8] Cherian MG, 2000, CELL MOL BIOL, V46, P347
  • [9] ECRG2, a novel candidate of tumor suppressor gene in the esophageal carcinoma, interacts directly with metallothionein 2A and links to apoptosis
    Cui, YP
    Wang, JB
    Zhang, XY
    Lang, RG
    Bi, MX
    Guo, LP
    Lu, SH
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 302 (04) : 904 - 915
  • [10] Expression of CD94/NKG2-A on human T lymphocytes is induced by IL-12: Implications for adoptive immunotherapy
    Derre, L
    Corvaisier, M
    Pandolfino, MC
    Diez, E
    Jotereau, F
    Gervois, N
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (10) : 4864 - 4870